Resources Contact Us Home
Internalizing anti-CD74 antibodies and methods of use

Image Number 15 for United States Patent #7931903.

The present invention provides humanized, chimeric and human anti-CD74 antibodies, CD74 antibody fusion proteins, immunoconjugates, vaccines and bispecific that bind to CD74, the major histocompatibility complex (MHC) class-II invariant chain, Ii, which is useful for the treatment and diagnosis of B-cell disorders, such as B-cell malignancies, other malignancies in which the cells are reactive with CD74, and autoimmune diseases, and methods of treatment and diagnosis.

  Recently Added Patents
Method and device for managing a turning setpoint applied to at least one turning actuator for the rear wheels of an automobile
Methods and apparatus to determine impressions using distributed demographic information
Power control arrangement for long term evolution time division duplex method and apparatus
Buckle (tube)
(-)-epigallocatechin gallate derivatives for inhibiting proteasome
System and method for multi-threaded MIMO OFDM channel equalizer
Field device configuration system
  Randomly Featured Patents
Machine tool having function of correcting mounting error through contact detection
Method and system for fast generation of file system snapshot bitmap in virtual environment
Electronic component feeding and mounting apparatus
Body armor vest for unobtrusive wear over a shirt
Method for percutaneous insertion of catheters
Apparatus for making a filter module
Tapered multi-chamber balloon
Dynamically variable machine readable binary code and method for reading and producing thereof
Manufactured articles, including fabrics comprising thermally bonded polyolefinic fibers
Defrostable outside rear view mirror for an automobile